Sponsors and Exhibitors

Industry & Exhibition Opportunities

12–15 June 2026 | Istanbul, Türkiye

Our industry sponsors are at the core of research and development that contributes to the continuous improvement of patient care.
They provide essential data, products, and resources that empower physicians in their daily practice and help improve patient outcomes.

The EAACI Congress 2026 will offer sponsors and exhibitors unique opportunities to connect with the global EAACI community.
The very latest developments in allergy and clinical immunology will be presented, discussed, and debated throughout the event.


Sponsorship Opportunities

For more information on sponsorship options, visit our EAACI Sponsor Online Platform (ESOP) by clicking here.

For additional sponsor-related information, please visit our Industry Service Centreclick here
(Please note: access to this area of the ESOP requires a unique username and password.)

————————————————————————–

Ensure you are at the forefront of research, and support Allergy and Immunology development by sharing Industry activities and attending the following:

Industry Symposia & Product Theatres

Delegates are invited to attend a series of Industry Symposia and Product Theatres included in the scientific programme of the Congress. All symposia and workshops offer relevant data on up-to-date scientific information and developments from the Industry.

Exhibition

Join us in meeting with key industry experts, exchange knowledge on critical areas of development and research in allergy and immunology.

The onsite exhibition will be open according to the main scientific programme timetable, subject to final adjustments.

  • Start of onsite Exhibition: 12 June 2025 – 9:00 (CET)
  • End of onsite Exhibition: 14 June 2025 – 17:30 (CET)

 

 

EAACI would like to thanks the past Annual Congress exhibitors and sponsors for their support:

  • A2M
  • ALK – Abelló
  • Allergopharma
  • Allergy Therapeutics
  • AllergoEye
  • American Academy of Allergy, Asthma & Immunology (AAAAI)
  • AstraZeneca PLC
  • Astria Therapeutics
  • Beckman Coulter
  • Bedfont Scientific Ltd
  • BioCryst Pharmaceuticals
  • Blueprint Medicines
  • Bühlmann Laboratories
  • Celldex Therapeutics
  • Celltrion, Inc.
  • Chiesi Farmaceutici
  • Cliantha Research
  • Cogent Biosciences
  • CSL Behring
  • DBV Technologies
  • Diater
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • EUROIMMUN AG
  • FAES Farma
  • GlaxoSmithKline plc
  • HAL Allergy
  • Hippo DX
  • Hycor Biomedical
  • InBio
  • Innova Nanojet Technologies
  • Inmunotek
  • Karger Publishers
  • KalVista Pharmaceuticals
  • LETI Pharma
  • Lofarma
  • MacroArray Diagnostics
  • Medscape Education
  • Med Learning Group
  • MENARINI GROUP
  • Nexkin Medical
  • Noucor
  • Novartis Pharma
  • NielMed Pharmaceuticals
  • Otsuka Pharmaceutical Europe
  • Pharming Group NV
  • Pharvaris
  • Probelte Pharma
  • Protia Inc.
  • Reacta Healthcare
  • Red Maple Trials
  • Royal College of Physicians
  • Sanofi Regeneron
  • Scibase
  • Siemens Healthineers
  • Stallergenes Greer
  • Swisens
  • Takeda
  • Tamakona
  • Thermo Fisher Scientific
  • Wisepress
  • World Allergy Organisation (WAO)

We are happy to assist companies in selecting the various Industry options at the EAACI Congress 2026. Please contact us at sponsors@eaaci.org to discuss the various options available.